Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

This study has been completed.
Sponsor:
Collaborator:
Sarcoma Alliance for Research through Collaboration
Information provided by (Responsible Party):
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT00642941
First received: March 19, 2008
Last updated: November 3, 2014
Last verified: November 2014